Previous close | 71.88 |
Open | 72.40 |
Bid | 70.17 x 900 |
Ask | 70.33 x 800 |
Day's range | 68.06 - 72.64 |
52-week range | 48.95 - 74.68 |
Volume | |
Avg. volume | 3,282,770 |
Market cap | 50.089B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 38.81 |
EPS (TTM) | 1.81 |
Earnings date | 02 May 2024 |
Forward dividend & yield | 2.18 (3.03%) |
Ex-dividend date | 06 May 2024 |
1y target est | N/A |
MetLife's (MET) first-quarter results benefit from improved variable investment income. However, poor performance in the Group Benefits segment partially offset the results.
The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Comprehensive Analysis of MetLife's Financial Performance and Market Positioning